Correlation Between DexCom and Nu Med
Can any of the company-specific risk be diversified away by investing in both DexCom and Nu Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Nu Med into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Nu Med Plus, you can compare the effects of market volatilities on DexCom and Nu Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Nu Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Nu Med.
Diversification Opportunities for DexCom and Nu Med
Pay attention - limited upside
The 3 months correlation between DexCom and NUMD is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Nu Med Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nu Med Plus and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Nu Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nu Med Plus has no effect on the direction of DexCom i.e., DexCom and Nu Med go up and down completely randomly.
Pair Corralation between DexCom and Nu Med
Given the investment horizon of 90 days DexCom Inc is expected to under-perform the Nu Med. But the stock apears to be less risky and, when comparing its historical volatility, DexCom Inc is 5.17 times less risky than Nu Med. The stock trades about -0.02 of its potential returns per unit of risk. The Nu Med Plus is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1.90 in Nu Med Plus on September 23, 2024 and sell it today you would lose (0.64) from holding Nu Med Plus or give up 33.68% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DexCom Inc vs. Nu Med Plus
Performance |
Timeline |
DexCom Inc |
Nu Med Plus |
DexCom and Nu Med Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DexCom and Nu Med
The main advantage of trading using opposite DexCom and Nu Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Nu Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nu Med will offset losses from the drop in Nu Med's long position.DexCom vs. Cigna Corp | DexCom vs. Definitive Healthcare Corp | DexCom vs. Guardant Health | DexCom vs. Laboratory of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |